The RMH model showed a clear trend of poorer prognosis with increasing scores [RMH score 1, HR 1.28 (95% CI: 0.96–1.70); RMH score 2, HR 2.27 (95% CI: 1.62–3.17); RMH score 3, HR 4.14 (95% CI: 2.62–6.53)].
← all excerpts
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
1
—
—